Robust Fluorometric Aptamer Assay for Direct and Rapid Detection of Clinical Isolates of Candida spec.
Yiting ZhangHu XingGrigory BolotnikovMarkus KrämerAnil BozdoganAnn-Kathrin KissmannTanja WeilBarbara SpellerbergSteffen StengerFrank RosenauPublished in: International journal of molecular sciences (2024)
Infections caused by yeasts of the genus Candida are likely to occur not only in immunocompromised patients but also in healthy individuals, leading to infections of the gastrointestinal tract, urinary tract, and respiratory tract. Due to the rapid increase in the frequency of reported Candidiasis cases in recent years, diagnostic research has become the subject of many studies, and therefore, we developed a polyclonal aptamer library-based fluorometric assay with high specificity and affinity towards Candida spec. to quantify the pathogens in clinical samples with high sensitivity. We recently obtained the specific aptamer library R10, which explicitly recognized Candida and evolved it by mimicking an early skin infection model caused by Candida using the FluCell-SELEX system. In the follow-up study presented here, we demonstrate that the aptamer library R10-based bioassay specifically recognizes invasive clinical Candida isolates, including not only C. albicans but also strains like C. tropcialis, C. krusei , or C. glabrata. The next-generation fluorometric bioassay presented here can reliably and easily detect an early Candida infection and could be used for further clinical research or could even be developed into a full in vitro diagnostic tool.
Keyphrases
- candida albicans
- biofilm formation
- gold nanoparticles
- sensitive detection
- end stage renal disease
- high throughput
- chronic kidney disease
- newly diagnosed
- pseudomonas aeruginosa
- peritoneal dialysis
- molecularly imprinted
- cystic fibrosis
- multidrug resistant
- mass spectrometry
- soft tissue
- respiratory failure
- wound healing